Research ArticleOriginal Articles
Open Access

Efficacy of repetitive paravertebral block combined with medication in the treatment of zoster-related pain with different courses

Fang Liu, Gui-Jun Lu and Zhi-Yong Bai
Neurosciences Journal April 2021, 26 (2) 192-198; DOI: https://doi.org/10.17712/nsj.2021.2.20200124

References

  1. 1.↵
    1. Van Wijck AJ,
    2. Wallace M,
    3. Mekhail N,
    4. van Kleef M.
    Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia. Pain Pract 2011; 11: 88–97.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.
    1. Arvin A. Aging
    , immunity, and the varicella-zoster virus. N Engl J Med 2005; 352: 2266–2267.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Levin MJ.
    Immune senescence and vaccines to prevent herpes zoster in older persons. Curr Opin Immunol 2012; 24: 494–500.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Dworkin RH,
    2. Portenoy RK.
    Pain and its persistence in herpes zoster. Pain 1996; 67: 241–251.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Gan EY,
    2. Tian EA,
    3. Tey HL
    1. Haanpää M,
    2. Rice ASC,
    3. Rowbotham MC.
    Treating herpes zoster and postherpetic neuralgia. Pain Clin Updates 2015; 23: 1–8. Gan EY, Tian EA, Tey HL. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol 2013;14(2):77-85.
    OpenUrl
  6. 6.↵
    1. Ji G,
    2. Niu J,
    3. Shi Y,
    4. Hou L,
    5. Lu Y,
    6. Xiong L.
    The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg 2009; 109: 1651–1655.
    OpenUrlCrossRefPubMed
  7. 7.
    1. Makharita MY,
    2. Amr YM,
    3. El-Bayoumy Y.
    Single paravertebral injection for acute thoracic herpes zoster: a randomized controlled trail. Pain Pract 2015; 15: 229–235.
    OpenUrl
  8. 8.
    1. Naja ZM,
    2. Maaliki H,
    3. Al-Tannir MA,
    4. El-Rajab M,
    5. Ziade F,
    6. Zeidan A.
    Repetitive paravertebral nerve block using a catheter technique for pain relief in post-herpetic neuralgia. Br J Anaesth 2006; 96: 381–383.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Kim HJ,
    2. Ahn HS,
    3. Lee JY,
    4. Choi SS,
    5. Cheong YS,
    6. Kwon K, et al.
    Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain 2017; 30: 3–17.
    OpenUrl
  10. 10.↵
    1. Davies RG,
    2. Myles PS,
    3. Graham JM.
    A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy-a systematic review and metaanalysis of randomized trials. Br J Anaesth 2006; 96: 418–426.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Kikuchi A,
    2. Kotani N,
    3. Sato T,
    4. Takamura K,
    5. Sakai I,
    6. Matsuki A.
    Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for longterm analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999; 24: 287–293.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Naja ZM,
    2. Maaliki H,
    3. Al-Tannir MA,
    4. El-Rajab M,
    5. Ziade F,
    6. Zeidan A.
    Repetitive paravertebral nerve block using a catheter technique for pain relief in postherpetic neuralgia. Br J Anaesth 2006; 96: 381–383.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Cohen JI.
    Clinical practice: Herpes zoster. N Engl J Med 2013; 369: 255–63.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Cunningham AL,
    2. Dworkin RH.
    The management of post-herpetic neuralgia. BMJ 2000; 321: 778–779.
    OpenUrlFREE Full Text
  15. 15.↵
    1. Bouhassira D,
    2. Chassany O,
    3. Gaillat J,
    4. Hanslik T,
    5. Launay O,
    6. Mann C.
    Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain 2012; 153: 342–9.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Ma Q,
    2. Lu AY. Pharmacogenetics
    , pharmacogenomics, and individualized medicine. Pharmacol Rev 2011; 63: 437–59.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Kleinschmidt-DeMasters BK,
    2. Gilden DH.
    Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001; 125: 770–780.
    OpenUrlPubMedWeb of Science
  18. 18.↵
    1. Van Wijck AJ,
    2. Wallace M,
    3. Mekhail N,
    4. van Kleef M.
    Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia. Pain Pract 2011; 11: 88–97.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Fields HL,
    2. Rowbotham M,
    3. Baron R.
    Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 1998; 5: 209–27.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Gater A,
    2. Abetz-Webb L,
    3. Carroll S,
    4. Mannan A,
    5. Serpell M,
    6. Johnson R.
    Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis 2014; 14: 402.
    OpenUrlCrossRefPubMed
  21. 21.
    1. Opstelten W,
    2. Zuithoff NP,
    3. van Essen GA,
    4. van Loon AM,
    5. van Wijck AJ,
    6. Kalkman CJ, et al.
    Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain 2007; 132: S52–S59.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Serpell M,
    2. Gater A,
    3. Carroll S,
    4. Abetz-Webb L,
    5. Mannan A,
    6. Johnson R.
    Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study. Health Qual Life Outcomes 2014; 12: 92.
    OpenUrl
  23. 23.↵
    1. Saguil A,
    2. Kane S,
    3. Mercado M,
    4. Lauters R.
    Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Am Fam Physician 2017; 96: 656–663.
    OpenUrlPubMed
  24. 24.↵
    Centre for Clinical Practice at NICE (UK)-National Institute for Health and Care Excellence: Clinical Guidelines. Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings. London: National Institute for Health and Clinical Excellence (UK); 2010 Mar.
  25. 25.↵
    1. Mallick-Searle T,
    2. Snodgrass B,
    3. Brant JM.
    Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Health 2016; 9: 447–454.
    OpenUrl
  26. 26.↵
    1. Wang J,
    2. Zhu Y.
    Different doses of gabapentin formulation for postherpetic neuralgia: a systematical review and meta-analysis of randomized controlled trials. J Dermatolog Treat 2016; 28: 65–77.
    OpenUrl
  27. 27.↵
    1. Opstelten W,
    2. van Wijck AJ,
    3. Stolker RJ.
    Interventions to prevent postherpetic neuralgia: cutaneous and percutaneous techniques. Pain 2004; 107: 202–206.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Wu CL,
    2. Marsh A,
    3. Dworkin RH.
    The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 2000; 87: 121–129.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Doran C,
    2. Yi X.
    The anti-inflammatory effect of local anesthetics. Pain Clin 2007; 19: 207–213.
    OpenUrl
  30. 30.↵
    1. Huang YC,
    2. Wang SJ,
    3. Young YH.
    Test Battery of Cranial Nerves VII and VIII for Assessing Herpes Zoster Oticus. Otolaryngol Head Neck Surg 2015; 152: 143–148.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Ping Zhao,
    2. Lisha MEI,
    3. Weizhi Wang
    . Clinical Study of Ultrasound-Guided Methylene Blue Thoracic Paravertebral Nerve Block for the Treatment of Postherpetic Neuralgia. Turk Neurosurg 2019; 29: 811–815.
    OpenUrl
  32. 32.↵
    1. Lee EG,
    2. Lee HJ,
    3. Hyun DJ,
    4. Min K,
    5. Kim DH,
    6. Yoon MS.
    Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. Dermatologic Therapy 2016; 29: 184–190.
    OpenUrl
  33. 33.↵
    1. Bulilete O,
    2. Leiva A,
    3. Rullán M,
    4. Roca A,
    5. Llobera J
    , PHN Group. Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: A double blind, randomized controlled trial. Plos One 2019; 14: e0217335.
    OpenUrl
  34. 34.↵
    1. Rice AS,
    2. Maton S.
    Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001; 94: 215–224.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Rowbotham M,
    2. Harden N,
    3. Stacey B,
    4. Bernstein P,
    5. Magnus-Miller L.
    Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837–1842.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Zhao P,
    2. Mei L.
    A Clinical Study of Paraspinal Nerve Block on Treatment of Herpes Zoster Under Ultrasonic Guidance. Neurochirurgie 2019; 65: 382–386.
    OpenUrl
  37. 37.↵
    1. Fan H,
    2. Yu W,
    3. Zhang Q.
    Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials. J Clin Pharm Ther 2014; 39: 334–342.
    OpenUrl
  38. 38.↵
    1. Wang D,
    2. Zhang K,
    3. Han S,
    4. Yu L.
    Pain-Vision apparatus for assessment of efficacy of pulsed radiofrequency combined with pharmacological therapy in the treatment of postherpetic neuralgia and correlations with measurements. BioMed Res Int 2017; 2017: 5670219.
    OpenUrl
  39. 39.
    1. Moriyama K.
    Effect of temporary spinal cord stimulation on postherpetic neuralgiain the thoracic nerve area. Neuromodulation 2009; 12: 39–43.
    OpenUrlPubMed
  40. 40.↵
    1. Lin CS,
    2. Lin YC,
    3. Lao HC,
    4. Chen CC.
    Interventional Treatments for Postherpetic Neuralgia: A Systematic Review. Pain Physician 2019; 22: 209–228.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section